MedPageToday -- CHICAGO -- Treating acute decompensated heart failure gains little from the addition of nesiritide (Natrecor), although the drug isn’t dangerous, according to results of a large international randomized trial.
MedPageToday -- CHICAGO -- Treating acute decompensated heart failure gains little from the addition of nesiritide (Natrecor), although the drug isn’t dangerous, according to results of a large international randomized trial.
